Loading…

Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice

Purpose Recently, there has been a growing interest in using ChatGPT for various applications in Medicine. We evaluated the interest of OpenAI chatbot (GPT 4.0) for drug information activities at Toulouse Pharmacovigilance Center. Methods Based on a series of 50 randomly selected questions sent to o...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical pharmacology 2023-10, Vol.79 (10), p.1375-1384
Main Authors: Montastruc, François, Storck, Wilhelm, de Canecaude, Claire, Victor, Léa, Li, Julien, Cesbron, Candice, Zelmat, Yoann, Barus, Romain
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Recently, there has been a growing interest in using ChatGPT for various applications in Medicine. We evaluated the interest of OpenAI chatbot (GPT 4.0) for drug information activities at Toulouse Pharmacovigilance Center. Methods Based on a series of 50 randomly selected questions sent to our pharmacovigilance center by healthcare professionals or patients, we compared the level of responses from the chatbot GPT 4.0 with those provided by specialists in pharmacovigilance. Results Chatbot answers were globally not acceptable. Responses to inquiries regarding the assessment of drug causality were not consistently precise or clinically meaningful. Conclusion The interest of chatbot assistance needs to be confirmed or rejected through further studies conducted in other pharmacovigilance centers.
ISSN:0031-6970
1432-1041
1432-1041
DOI:10.1007/s00228-023-03547-8